Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Sage, Biogen Report Results From Phase 2 KINETIC 2 Study Of SAGE-324 (BIIB124) For Essential Tremor; Did Not Demonstrate Statistically Significant Dose-Response Relationship On Primary Endpoint

Author: Benzinga Newsdesk | July 24, 2024 06:33am

Posted In: BIIB SAGE